Sanofi Dengue Bid Seen as $2.6 Billion Hit or Major Flop

Sanofi Dengue Bid Seen as $2.6 Billion Hit or Major Flop

Sanofi via Bloomberg

Sanofi is making the first batches of the vaccine at its new 300 million-euro ($398 million) plant, even as it waits for results next year of make-or-break trials to determine whether the product will be a $2.6 billion-a-year success or an $800 million flop.